Segall Bryant & Hamill, LLC Insmed Inc Call Options Transaction History
Segall Bryant & Hamill, LLC
- $7.16 Billion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding INSM
# of Institutions
467Shares Held
182MCall Options Held
2.27MPut Options Held
3.33M-
Vanguard Group Inc Valley Forge, PA17.1MShares$1.29 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY14.3MShares$1.07 Billion0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD12.6MShares$946 Million0.11% of portfolio
-
Darwin Global Management, Ltd. St. Helier, Y910.5MShares$789 Million62.32% of portfolio
-
Capital International Investors Los Angeles, CA6.52MShares$490 Million0.09% of portfolio
About INSMED Inc
- Ticker INSM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 135,476,992
- Market Cap $10.2B
- Description
- Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...